Skip to main content
Log in

Lipoproteinveränderungen unter Clofibrat bei Typ IV-Hyperlipoproteinämien

Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia

  • Originalien
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

The effect of clofibrate treatment (1.5 g/day for four weeks) on triglycerides, cholesterol and phospholipids in very low density lipoproteins (VLDL), low density lipoproteins (LDL) and high density lipoproteins (HDL) was investigated in 12 patients with type IV hyperlipoproteinaemia. The decrease of serum triglycerides was due to the reduction of VLDL-triglycerides. Furthermore, LDL-hypertriglyceridemia was normalised by clofibrate. — There existed a significant decrease of VLDL- und HDL-cholesterol as well as of VLDL-phospholipids.

The changes in LDL-cholesterol and LDL-phospholipids by clofibrate depended on their initial concentrations which were negatively correlated to the serum triglycerides before treatment. — The normalisation of lipid concentrations in VLDL and LDI could be explained by a stimulated delipidation of the apo B-lipoproteins.

Zusammenfassung

Der Einfluß einer vierwöchigen Clofibratbehandlung auf den Triglycerid-, Cholesterin-und Phospholipidgehalt von Very Low Density Lipoproteins (VLDL), Low Density Lipoproteins (LDL) und High Density Lipoproteins (HDL) wurde bei 12 Patienten mit primärer Typ IV-Hyperlipoproteinämie untersucht. Die Senkung der Serumtriglyceride war durch einen Abfall der VLDL-Triglyceride bedingt. Darüber hinaus kam es zu einer Normalisierung der zum Teil nachweisbaren LDL-Hypertriglyceridämie. — Die Cholesterinkonzentration nahm in den VLDL und HDL, der Phospholipidgehalt nur in den VLDL signifikant ab. In den LDL änderten sich diese beiden Lipide in Abhängigkeit von ihren Ausgangswerten, die negativ mit den Serumtriglyceridkonzentrationen korrelierten. Die Normalisierung von VLDL- und LDL-Lipiden könnte mit einer beschleunigten Delipidation der Apo-B-Lipoproteine erklärt werden.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Literatur

  1. Brown, H.B., Lewis, L.A., Page, I.H.: Effects of clofibrate and a fat-modified diet on serum lipids. Clin. Pharmacol. Ther.17, 171 (1975)

    PubMed  Google Scholar 

  2. Burstein, M., Scholnick, H.R., Morfin, R.: Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J. Lipid Res.11, 583 (1970)

    PubMed  Google Scholar 

  3. Carlson, L.A., Olsson, A.G., Orö, L., Rössner, St., Walldius, G.: Effects of hypolipidemic regimes on serum lipoproteins. Proc. of the Third Intern. Symp. on Atherosclerosis, Berlin 1973. In: Atherosclerosis III, ed.: G. Schettler, p. 768. Berlin-Heidelberg-New York: Springer 1974

    Google Scholar 

  4. Documenta Geigy, Wissenschaftliche Tabellen, 1960

  5. Eggstein, M., Kreutz, F.H.: Eine neue Bestimmung der Neutralfette im Blutserum und Gewebe. Klin. Wschr.44, 262 (1966)

    PubMed  Google Scholar 

  6. Eisenberg, S.: Lipoprotein metabolism and hyperlipemia. Atherosclerosis Reviews1, ed. R. Paoletti, A.M. Gotto, S. 23. New York: Raven Press 1976

    Google Scholar 

  7. Fiske, C.H., Subbarow, Y.: The colorimetric determination of phosphorus. J. biol. Chem.66, No. 2, 375 (1925)

    Google Scholar 

  8. Folch, J., Lees, M., Sloane Stanley, G.H.: A simple method for the isolation and purification of total lipids from animal tissues. J. biol. Chem.226, 497 (1957)

    PubMed  Google Scholar 

  9. Havel, R.J., Eder, H.A., Bragdon, J.H.: The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. clin. Invest34, 1345 (1955)

    PubMed  Google Scholar 

  10. Havel, R.J., Kane, J.P., Balasse, E.O., Segel, N., Basso, L.V.: Splanchnic metabolism of free fatty acids and production of triglycerides of very low density lipoproteins in normotriglyceridemic and hypertriglyceridemic humans. J. clin. Invest.49, 2017 (1970)

    PubMed  Google Scholar 

  11. Levy, R.I., Fredrickson, D.S., Shulman, R., Bilheimer, D.W., Breslow, J.L., Stone, N.J., Lux, S.E., Sloan, H.R., Krauss, R.M., Herbert, P.N.: Dietary and drug treatment of primary hyperlipoproteinemia. Ann. intern. Med.77, 267 (1972)

    PubMed  Google Scholar 

  12. Miller, G.J., Miller, N.E.: Plasma-high-density-lipoprotein concentration and development of ischaemic heart disease. Lancet 1975I, 16

  13. Morganroth, J., Levy, R.I.: The diagnosis and management of the hyperlipoproteinemias. In: Drug in cardiology, ed.: E. Donoso, p. 127. New York: Medical Book Corp 1975

    Google Scholar 

  14. Noble, R.P.: Electrophoretic separation of plasma lipoproteins in agarosegel. J. Lipid Res.9, 693 (1968)

    PubMed  Google Scholar 

  15. Olsson, A.G., Orö, L., Rössner, S.: Dose-response effect of single and combined clofibrate (Atromid®) and nicitrol (Perycit®) treatment on serum lipids and lipoproteins in type II hyperlipoproteinemia.

  16. Quarfordt, S.H., Frank, A., Shames, D.M., Berman, M., Steinberg, D.: Very low density lipoprotein triglyceride transport in type IV hyperlipoproteinemia and the effects of carbohydrate-rich diets. J. clin. Invest.49, 2281 (1970)

    PubMed  Google Scholar 

  17. Radding, Ch.M., Steinberg, D.: Studies on the synthesis and secretion of serum lipoproteins by rat liver slices. J. clin. Invest.39, 1560 (1960)

    PubMed  Google Scholar 

  18. Reaven, G.M., Lerner, R.L., Stern, M.P.: Role of insulin in endogenous hypertriglyceridemia. J. clin. Invest.46, 1756 (1967)

    PubMed  Google Scholar 

  19. Röschlau, P., Bernt, E., Gruber, W.: Enzymatische Bestimmung des Gesamtcholesterins im Serum. Z. klin. Chem.12, 403 (1974)

    Google Scholar 

  20. Sailer, S., Bolzano, K., Sandhofer, F.: Triglyceridspiegel und Insulinkonzentration im Plasma nach oraler Glukosegabe bei Patienten mit primärer kohlenhydratinduzierter Hypertriglyceridämie. Schweiz. med. Wschr.98, 1512 (1968)

    PubMed  Google Scholar 

  21. Seidel, D., Wieland, H., Ruppert, C.: Improved techniques for assessment of plasma lipoprotein patterns. I. Precipitation in gels after electrophoresis with polyanionic compounds. Clin. Chem.19/7, 737 (1973)

    PubMed  Google Scholar 

  22. Shames, D.M., Frank, A., Steinberg, D., Berman, M.: Transport of plasma free fatty acids and triglycerides in man: a theoretical analysis. J. clin. Invest.49, 2298 (1970)

    PubMed  Google Scholar 

  23. Strisower, E.H., Adamson, G., Strisower, B.: Treatment of hyperlipidemias. Amer. J. Med.45, 488 (1968)

    PubMed  Google Scholar 

  24. Vessby, B., Lithell, H., Boberg, J., Werner, J.: Effect of PASC® on serum lipoproteins when combined with lipid lowering diet and clofibrate. Artery2, 70 (1976)

    Google Scholar 

  25. Wilson, D.E., Lees, R.S.: Metabolic relationship among the plasma lipoproteins. Reciprocal changes in the concentrations of very low and low density lipoproteins in man. J. clin. Invest.51, 1051 (1971)

    Google Scholar 

  26. Wolfe, B.M., Kane, Y.P., Havel, R.J., Brewster, H.P.: Mechanism of the hypolipemic effect of clofibrate in postabsorptive man. J. clin. Invest.52, 2146 (1973)

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weisweiler, P., Schwandt, P. Lipoproteinveränderungen unter Clofibrat bei Typ IV-Hyperlipoproteinämien. Klin Wochenschr 55, 791–794 (1977). https://doi.org/10.1007/BF01651267

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01651267

Key words

Schlüsselwörter

Navigation